Samuraciclib (ICEC0942) hydrochloride

Samuraciclib (ICEC0942) hydrochloride is a new, orally bioavailable CDK7 inhibitor with an IC50 of 40nM. The IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher. ICEC0942 (CT7001) promotes cell cycle arrest and apoptosis.

Trivial name CT7001 hydrochloride
Catalog Number S8722
Molecular Formula C22H31ClN6O
CAS# 1805789-54-1
Inchi InChI=1S/C22H30N6O.ClH/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29;/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27);1H/t17-,19+;/m1./s1
Inchi Key YMNPLAHCOLEZJE-ZFNKBKEPSA-N
SMILES CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NCC4CCNCC4O.Cl
Size 25mg
Supplier Page http://www.selleckchem.com/products/icec0942-hydrochloride.html
Additional Information https://file.selleck.cn/downloads/struct/icec0942-chemical-structure-s8722.gif